RATIONALE: Pseudomonas aeruginosa, a major problem pathogen responsible for severe infections in critically ill patients, triggers, through a functional type-3 secretion system (T3SS), the activation of an intracellular cytosolic sensor of innate immunity, NLRC4. Although the NLRC4-inflammasome-dependent response contributes to increased clearance of intracellular pathogens, it seems that NLRC4 inflammasome activation decreases the clearance of P. aeruginosa, a mainly extracellular pathogen. OBJECTIVES: We sought to determine the underlying mechanisms of this effect of the activation of NLRC4 by P. aeruginosa. METHODS: We established acute lung injury in wild-type and Nlrc4(-/-) mice using sublethal intranasal inocula of P. aeruginosa strain CHA expressing or not a functional T3SS. We studied 96-hour survival, lung injury, bacterial clearance from the lungs, cytokine secretion in bronchoalveolar lavage, lung antimicrobial peptide expression by quantitative polymerase chain reaction, and flow cytometry analysis of lung cells. MEASUREMENTS AND MAIN RESULTS: Nlrc4(-/-) mice showed enhanced bacterial clearance and decreased lung injury contributing to increased survival against extracellular P. aeruginosa strain expressing a functional T3SS. The mechanism involved decreased NLRC4-inflammasome-driven IL-18 secretion attenuating lung injury caused by excessive neutrophil recruitment. Additionally, in the lungs of Nlrc4(-/-) mice secretion of IL-17 by innate immune cells was increased and responsible for increased expression of lung epithelial antimicrobial peptides. Furthermore, IL-18 secretion was found to repress IL-17 and IL-17-driven lung antimicrobial peptide expression. CONCLUSIONS: We report a new role of the T3SS apparatus itself, independently of exotoxin translocation. Through NLRC4 inflammasome activation, the T3SS promotes IL-18 secretion, which dampens a beneficial IL-17-mediated antimicrobial host response.
RATIONALE: Pseudomonas aeruginosa, a major problem pathogen responsible for severe infections in critically illpatients, triggers, through a functional type-3 secretion system (T3SS), the activation of an intracellular cytosolic sensor of innate immunity, NLRC4. Although the NLRC4-inflammasome-dependent response contributes to increased clearance of intracellular pathogens, it seems that NLRC4 inflammasome activation decreases the clearance of P. aeruginosa, a mainly extracellular pathogen. OBJECTIVES: We sought to determine the underlying mechanisms of this effect of the activation of NLRC4 by P. aeruginosa. METHODS: We established acute lung injury in wild-type and Nlrc4(-/-) mice using sublethal intranasal inocula of P. aeruginosa strain CHA expressing or not a functional T3SS. We studied 96-hour survival, lung injury, bacterial clearance from the lungs, cytokine secretion in bronchoalveolar lavage, lung antimicrobial peptide expression by quantitative polymerase chain reaction, and flow cytometry analysis of lung cells. MEASUREMENTS AND MAIN RESULTS:Nlrc4(-/-) mice showed enhanced bacterial clearance and decreased lung injury contributing to increased survival against extracellular P. aeruginosa strain expressing a functional T3SS. The mechanism involved decreased NLRC4-inflammasome-driven IL-18 secretion attenuating lung injury caused by excessive neutrophil recruitment. Additionally, in the lungs of Nlrc4(-/-) mice secretion of IL-17 by innate immune cells was increased and responsible for increased expression of lung epithelial antimicrobial peptides. Furthermore, IL-18 secretion was found to repress IL-17 and IL-17-driven lung antimicrobial peptide expression. CONCLUSIONS: We report a new role of the T3SS apparatus itself, independently of exotoxin translocation. Through NLRC4 inflammasome activation, the T3SS promotes IL-18 secretion, which dampens a beneficial IL-17-mediated antimicrobial host response.
Authors: Sebastián A Riquelme; Kalle Liimatta; Tania Wong Fok Lung; Blanche Fields; Danielle Ahn; David Chen; Carmen Lozano; Yolanda Sáenz; Anne-Catrin Uhlemann; Barbara C Kahl; Clemente J Britto; Emily DiMango; Alice Prince Journal: Cell Metab Date: 2020-05-18 Impact factor: 27.287
Authors: Lori F Gentile; Angela L Cuenca; Alex G Cuenca; Dina C Nacionales; Ricardo Ungaro; Philip A Efron; Lyle L Moldawer; Shawn D Larson Journal: Immunology Date: 2015-06 Impact factor: 7.397
Authors: Kosuke Kato; Alec D Hanss; Marina A Zemskova; Nicole E Morgan; Marianne Kim; Kenneth S Knox; Yong Lin; Erik P Lillehoj; Kwang Chul Kim Journal: Biochem Biophys Res Commun Date: 2017-08-16 Impact factor: 3.575
Authors: Sangeetha Ravi Kumar; Sagar Paudel; Laxman Ghimire; Scott Bergeron; Shanshan Cai; Rachel L Zemans; Gregory P Downey; Samithamby Jeyaseelan Journal: Am J Respir Crit Care Med Date: 2018-01-15 Impact factor: 21.405
Authors: Pankaj Baral; Sanjay Batra; Rachel L Zemans; Gregory P Downey; Samithamby Jeyaseelan Journal: Am J Respir Crit Care Med Date: 2014-10-01 Impact factor: 21.405